AzTrials
AzTrials

StrokeTCSD-SNCT03452813

Transitions of Care Stroke Disparity Study (TCSD-S)

An observational study of Stroke, run by University of Miami at 2 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The TCSD Study will identify disparities in transitions of stroke care and key factors associated with effective transitions of care through structured telephone interviews to evaluate medication adherence, healthy lifestyle, utilization of rehabilitation interventions and medical follow-up 30 days after hospital… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Stroke
How many people
1,549 participants
Where
2 sitesUnited States
Study dates
1 Jun 2018to 11 Dec 2023
How long will I take part?
3 Months
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: The TCSD-S participating study sites (SS) include 6 Comprehensive Stroke Centers (CSC) that currently participate in the Florida Stroke Registry will be Study. The SS will identify and consent participants and collect TOSC performance metrics and outcomes. A total of 2,400 ischemic stroke and intracerebral hemorrhage participants from 6 Florida CSC that are discharged directly to home will be enrolled in this study.

Who may be able to join

  • Ischemic stroke or intracerebral hemorrhage patients age >/=18 years that are discharged directly to home, or discharged to rehab
  • Final diagnosis of ischemic stroke or intracerebral hemorrhage, included in the Get With
  • The Guidelines- Stroke (GWTG-S) database.
  • Patient or legally authorized representative provides consent
  • Available by phone and willing to receive two follow-up calls.

Who cannot join

  • Cases with subarachnoid hemorrhage, transient ischemic attack (TIA), stroke not otherwise specified, no stroke related diagnosis, and admission for elective carotid intervention will be excluded.
  • Prisoners will be excluded. The purpose of the project is to study the hospital-to-home transition of stroke care.
  • Discharged to inpatient rehabilitation, nursing home, subacute rehabilitation facilities or assisted living facilities. These facilities support medication adherence, provide prescribed diets, often provide in-house medical follow-up, and therefore disparities in TOSC are less likely to be detected and not amenable to the proposed interventions.
  • Modified Rankin Scale of 0 after stroke. These individuals usually do not require any rehabilitation interventions and to avid the inclusion of predominately mild stroke patients.
  • Unable to obtain consent from patient or legally authorized representative.
  • Unavailable or unwilling to participate in the 30 and 90 day follow up telephone calls.

Trial locations and contacts

2 sites in 1 country.

United States2 sites
  • Jackson Memorial Hospital

    Miami, Florida, 33136

  • University of Miami

    Miami, Florida, 33136

Other trials in United States

About this study

The TCSD Study will identify disparities in transitions of stroke care and key factors associated with effective transitions of care through structured telephone interviews to evaluate medication adherence, healthy lifestyle, utilization of rehabilitation interventions and medical follow-up 30 days after hospital discharge to home in 2,400 participants across 12 comprehensive stroke centers (CSC) in Florida. A novel Transitions of Stroke Care Performance Index (TOSC PI) correlated with 90-day rehospitalization will be derived and validated.

Read the detailed description

The TCSD Study will identify disparities in transitions of stroke care and key factors associated with effective transitions of care through structured telephone interviews to evaluate medication adherence, healthy lifestyle, utilization of rehabilitation interventions and medical follow-up 30 days after hospital discharge to home and in-patient care rehabilitation in 2,400 participants across 12 comprehensive stroke centers (CSC) in Florida. A novel Transitions of Stroke Care Performance Index (TOSC PI) will be derived and validated. The primary outcomes are the TOSC PI and 90-day readmission. Other stroke outcomes include stroke disability, recurrence, cardiovascular events, and death at 3 months. Outcomes will be collected through telephone interviews and review of patient charts. Predictors of disparities in transition of care and outcomes will be evaluated using baseline in-hospital data during acute stroke hospitalization obtained from the Florida Stroke Registry and Social Determinants of Health obtained through novel data collected from publicly available records. Based on identified predictors of disparities in TOSC, we will develop and demonstrate feasibility of initiatives for interventions to reduce disparities in TOSC that target systems of care with a TOSC disparities dashboard, and health care providers with a training module for enhanced education and support at discharge and during follow-up. We will evaluate any temporal improvements in the TOSC Performance Index and outcomes before and after the interventions.

Conditions
Stroke
Keywords
transitions of care, stroke disparities
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT03452813
Study groupRoleWhat they receive
ischemic stroke or intracerebral hemorrhage patientspatients discharged from hospital to home or discharged to rehab will be called at 30 day and 90 day to monitor their transition of care outcomes.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Transitions of Stroke Care Performance Index

    Transitions of Stroke Care Performance Index (TOSC-PI) is a novel score that will be developed based on the results of this study to predict effective transitions of care, and will be composite score that includes medication and lifestyle adherence, diet, tobacco and alcohol cessation, exercise, utilization of rehabilitation services, and medical follow-up after discharge. The index will be calculated as the points achieved over the total for which the participant is eligible. High scores indicate successful transition of care, while low scores reflect inadequacies and gaps in transitions of care.

    Measured: 30 days

  2. Hospital readmission

    Review and documentation of the participants readmission to hospital within 90 days post discharge

    Measured: 90 days

Secondary outcomes (4)
  1. Modified Rankin Scale (mRS)

    Measurement of participants degree of disability/dependence in daily activities. The scale runs from 0 (No symptoms at all) to 6 (dead).

    Measured: 90 days

  2. Stroke recurrence

    documentation of the number of times a participant has experienced another stroke.

    Measured: 90 days

  3. Cardiovascular events

    incident cardiovascular events

    Measured: 90 days

  4. Mortality rate

    number of deaths

    Measured: 90 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Mar 2018
  2. Study start1 Jun 2018
  3. Primary completion30 Jun 2023
  4. Study completion11 Dec 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
1,549 participants (actual)
Target duration
3 Months
IDs, dates and publications
ClinicalTrials.gov ID
NCT03452813
Sponsor's protocol ID
20170892
Other IDs
1R01MD012467, 20170892
Acronym
TCSD-S
Status last verified
Apr 2024
First submitted
26 Feb 2018
Last updated
16 Apr 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Veledar E, Zhou L, Veledar O, Gardener H, Gutierrez CM, Brown SC, Fakoori F, Johnson KH, Del Brutto VJ, Alkhachroum A, Rose DZ, Perue GG, Asdaghi N, Romano JG, Rundek T. Identifying determinants of readmission and death post-stroke using explainable machine learning. PLoS One. 2025 Sep 18;20(9):e0332371. doi: 10.1371/journal.pone.0332371. eCollection 2025.

    PubMed 40966264
  • Dong C, Gardener H, Rundek T, Marulanda E, Gutierrez CM, Campo-Bustillo I, Gordon Perue G, Johnson KH, Sacco RL, Romano JG; Transitions of Care Stroke Disparities Study (TCSD-S) Investigatorsdagger. Factors and Behaviors Related to Successful Transition of Care After Hospitalization for Ischemic Stroke. Stroke. 2023 Feb;54(2):468-475. doi: 10.1161/STROKEAHA.122.040891. Epub 2022 Dec 19.

    PubMed 36533520

Questions about this trial

What is this clinical trial studying?

An observational study of Stroke, run by University of Miami at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Transitions of Stroke Care Performance Index (time frame: 30 days). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03452813, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Apr 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in